BackgroundPsilocybin Therapy (PT) is being increasingly studied as a psychiatric
intervention. Personality relates to mental health and can be used to probe the nature of PT's …

Objective To explore whether psilocybin with psychological support modulates personality
parameters in patients suffering from treatment‐resistant depression (TRD). Method Twenty …

Background Psilocybin therapy is receiving attention as a mental health intervention with
transdiagnostic potential. In line with psychotherapeutic research, qualitative research has …

Background Psilocybin may have antidepressant properties, but direct comparisons
between psilocybin and established treatments for depression are lacking. Methods In a …

Background: Preliminary data suggest that psilocybin-assisted treatment produces
substantial and rapid antidepressant effects in patients with major depressive disorder …

Background: Several early phase studies have demonstrated that psilocybin-assisted
therapy has rapid-acting and persisting antidepressant effects from just one or two doses …

Rationale Recent clinical trials are reporting marked improvements in mental health
outcomes with psychedelic drug-assisted psychotherapy. Objectives Here, we report on …

The mechanisms by which Psilocybin Therapy (PT) improves depression remain an
important object of study, with scientists actively exploring acute psychological experiences …

Background: Psilocybin, a psychoactive serotonin receptor partial agonist, has been
reported to acutely reduce clinical symptoms of depressive disorders. Psilocybin's effects on …

Psilocybin as a novel treatment for depression is garnering a lot of attention from both the
mainstream media and the academic community. Although phase 3 trials are only just …